Telesis Bio
(NASDAQ:TBIO)
$0.425
-0.025[-5.56%]
At close: Mar 28
$0.425
0[0.00%]
After Hours: 7:05PM EDT
Q4 2023 Earnings were released on Thu Mar 28th, after the market close
Consensus Rating1
Market Perform
Highest Price Target1
$0.00
Lowest Price Target1
$0.00
Consensus Price Target1
$19.00

Telesis Bio Stock (NASDAQ:TBIO), Analyst Ratings, Price Targets, Predictions

Telesis Bio Inc has a consensus price target of $19, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released from Keybanc, Roth Capital, and SVB Leerink on August 11, 2023, August 4, 2021, and August 3, 2021. With an average price target of $25.33 between Keybanc, Roth Capital, and SVB Leerink, there's an implied 5860.78% upside for Telesis Bio Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Feb
0
0
0
0
0
Jan
0
0
0
0
0
Dec 23
0
0
0
0
0
Nov 23
0
0
0
0
0
Oct 23
0
0
0
0
0
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Keybanc
Roth Capital
SVB Leerink
William Blair
SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Telesis Bio

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
08/11/2023TBIOBuy Now
Telesis Bio
$0.42Keybanc
Paul Knight
DowngradeOverweight → Sector WeightGet Alert
08/04/2021TBIOBuy Now
Translate Bio
$0.428841.18%Roth Capital
Tony Butler
MaintainsNeutralGet Alert
08/03/2021TBIOBuy Now
Translate Bio
$0.428841.18%SVB Leerink
Geoffrey Porges
MaintainsMarket PerformGet Alert
08/03/2021TBIOBuy Now
Translate Bio
$0.42William Blair
Myles Minter
DowngradeOutperform → Market PerformGet Alert
07/26/2021TBIOBuy Now
Translate Bio
$0.4210488.24%Roth Capital
Tony Butler
MaintainsBuyGet Alert
05/10/2021TBIOBuy Now
Translate Bio
$0.424370.59%SVB LeerinkMaintainsMarket PerformGet Alert

FAQ

Q

What is the target price for Telesis Bio (TBIO)?

A

The latest price target for Telesis Bio (NASDAQ: TBIO) was reported by Keybanc on August 11, 2023. The analyst firm set a price target for $0.00 expecting TBIO to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Telesis Bio (TBIO)?

A

The latest analyst rating for Telesis Bio (NASDAQ: TBIO) was provided by Keybanc, and Telesis Bio downgraded their sector weight rating.

Q

When was the last upgrade for Telesis Bio (TBIO)?

A

There is no last upgrade for Telesis Bio.

Q

When was the last downgrade for Telesis Bio (TBIO)?

A

The last downgrade for Telesis Bio Inc happened on August 11, 2023 when Keybanc changed their price target from N/A to N/A for Telesis Bio Inc.

Q

When is the next analyst rating going to be posted or updated for Telesis Bio (TBIO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Telesis Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Telesis Bio was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.

Q

Is the Analyst Rating Telesis Bio (TBIO) correct?

A

While ratings are subjective and will change, the latest Telesis Bio (TBIO) rating was a downgraded with a price target of $0.00 to $0.00. The current price Telesis Bio (TBIO) is trading at is $0.43, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch